Skip to content

Your must-see guide to RSNA 2025

Explore
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
featured-image

Press Release

Rapid Celebrates Record-Breaking Year in Stroke Care

Rapid announces record-breaking performance metrics for 2019 Menlo Park, Calif. —January, 23 2020 –RAPID, the worldwide leader in advanced imaging for stroke, today announced record-breaking performance metrics for 2019. Newly released numbers reveal accelerating growth in the number of countries and hospitals where RAPID is available and in use, as well as over 100% growth in the number of scans processed. As RAPID brought AI enhanced stroke imaging to more of the world, the company also launched innovative new imaging products and supported critical new stroke research. The RAPID artificial intelligence framework helps to quantify brain lesions and extends the window of potential stroke intervention from six hours after onset to up to 24 hours, for patients with salvageable brain tissue. RAPID provides physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke. In 2019, RAPID: Expanded its worldwide footprint to 50 countries, including Vietnam, Israel and Mexico Grew adoption to over 1,500 hospitals, including major networks and systems around the world Processed over 650,000 stroke imaging scans Continued to set the standard in research, surpassing 40 research studies, including a total of 15 multicenter, multinational stroke clinical trials In addition to record-breaking availability, growth and usage, in 2019, RAPID also introduced: RAPID ICH: a fully-automated system that uses the latest in artificial intelligence to quickly triage non-contrast CT (NCCT) cases and notify clinicians of possible intracranial hemorrhage (ICH). RAPID ICH can detect all types of brain hemorrhages with a sensitivity and specificity greater than 90%. RAPID LVO detection and localization: a critical new feature within RAPID CTA that makes it the only advanced imaging product indicated for localization of a detected Large Vessel Occlusion (LVO). RAPID CTA can now detect LVOs with a sensitivity of 95% and specificity of 90%, and immediately notifies a stroke team when an LVO is detected. RAPID CTP enhancements: advanced motion correction, AIF selection improvement and ventricle masking.  RAPID Mobile app enhancements: the leading mobile stroke imaging experience added HIPAA-compliant in-app messaging for more efficient care coordination across stroke teams and sites, real-time message notification as well as capture of clinical data to align stroke teams on key patient information. RAPID U: a new learning system and certification program that sets the international standard for professional status as a RAPID imaging practitioner. Role-based learning modules empower multiple members of stroke care teams to quickly become proficient. RAPID U is a resource-rich learning platform enhanced with videos, case studies, and publications. In 2019, RAPID also introduced innovations in AI-enhanced stroke imaging to enable Mobile Stroke Units (MSU) as well as expanded cloud and on-premise availability, to meet the needs of every hospital and stroke team. “Last year we redoubled our efforts to bring the most advanced AI-enhanced stroke imaging platform to every part of the world, and through innovation and a dedication to our mission, we beat even our most aggressive estimates,” said Don Listwin, CEO of RAPID. “Aside from records in usage and availability, we were able to launch RAPID 5.0, RAPID ICH and RAPID U. 2019 was a gratifying year. We now again commit ourselves to making the best even better, and helping improve stroke outcomes everywhere.” Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID artificial intelligence framework combines deep learning, machine learning and expert feature extraction. It is the only clinically validated imaging solution for stroke diagnostic support worldwide.
featured-image

Press Release

Rapid Advanced Medical Imaging for Stroke Now Installed in Vietnam

Rapid expands worldwide reach to bring Vietnam the only clinically validated, next generation imaging platform for assessing stroke Menlo Park, Calif. — December 17, 2019 – RAPID, the worldwide leader in advanced imaging for stroke, is now available and installed in Vietnam. The RAPID artificial intelligence framework helps to quantify brain lesions and extend the window of potential stroke intervention from six hours after onset to up to 24 hours, for patients with salvageable brain tissue. RAPID provides physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke. According to the Vietnam Stroke Association, there are approximately 200,000 new stroke cases every year, 90% of which have long term consequnces and complications. Hospitals and clinics that treat stroke in Vietnam will now have access to the RAPID automated CTP, MRI, CTA, ASPECTS and ICH solutions, as well as their unique mobile app that accelerates the provision of information to support treatment decisionmaking. RAPID’s expansion into Vietnam represents continued market growth across Asia, and is further confirmation that RAPID has become the de facto standard for stoke imaging around the world. "Strokes are a medical emergency, and urgent treatment is essential. However, only about 19% of patients arrive at our hospitals within 4-6 hours after experiencing stroke symptoms,” commented Dr. Thang Huy Nguyen, Senior Stroke Consultant, Head of Department of Cerebrovascular Disease, 115 People's Hospital. “The RAPID technology provides physicians and stroke teams the ability to diagnose more stroke patients by extending the treatment window up to 24 hours. Moving forward our teams will be able to utilize this advanced technology via the RAPID platform to promptly address more cases with the highest efficiency.” Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed stroke treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. It is the only clinically validated imaging solution for stroke diagnostic support worldwide. In 2019, this proven platform is being used for more than 400,000 scans by thousands of healthcare professionals in over 45 countries. The Complete RAPID Platform includes: RAPID CTP: fully-automated perfusion maps; accurately quantifies reduced cerebral blood flow, cerebral blood volume and transit time RAPID MRI: fully-automated diffusion and perfusion maps that quantify brain areas with low ADC values, as well as delayed contrast arrival RAPID CTA: automatically delivers CT angiography maps and identifies brain regions with reduced blood vessel density in 2D and 3D outputs RAPID ASPECTS: automatically identifies areas of early ischemic change on noncontrast CT scans, which predicts irreversible injury RAPID ICH : automatically triages non-contrast CT scans to quickly identify brain hemorrhages with a sensitivity and specificity >90% RAPID Mobile: securely preview RAPID results from multiple sites with customizable notifications on mobile devices “With RAPID in Vietnam we continue to extend the global footprint to give more hospitals the tools they need to help stroke patients achieve the best possible outcomes and quality of life,” said Anil Singhal, MD, SVP, Worldwide Operations at RAPID. “Vietnamese hospitals are already reporting positive outcomes that may not have been possible prior to RAPID being available. We are very proud to be partnering with these facilities to help provide the best care for their patients.” For more information about working with RAPID in Vietnam and across Asia, contact Alex Oh, VP International Sales for APAC at +1 (949) 232-3365 or Oh@RAPID.ai .
featured-image

Press Release

Rapid Releases New Stroke Imaging Trends For World Stroke Day

Stroke Care and Imaging is Expanding Quickly, Bringing Life-Saving Treatment Opportunities to More People Around the World. In the US, Major Growth is Occurring at Primary Stroke Centers, Indicating Expansion in Rural and Suburban Areas San Francisco, Calif. –October 29, 2019 – To commemorate World Stroke Day, RAPID, the worldwide leader in advanced imaging for stroke, is releasing new global stroke findings. The RAPID platform will process over 400,000 scans this year and has uncovered compelling data around stroke imaging based on the large number of scans processed to date. Findings include triple-digit increases in stroke imaging since new American Heart Association (AHA) and American Stroke Association (ASA) treatment guidelines were established at the beginning of 2018. They also reveal a large expansion in imaging studies performed in suburban and rural areas, as imaging at Primary Stroke Centers (PSC) increased substantially. The RAPID platform is designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke. From 2017 to 2018 there was over a 250% increase in patients imaged with RAPID worldwide. Additionally, RAPID has already imaged over 211,000 patients in the first three quarters of 2019 and identified over 47,000 potential patients for thrombectomies (minimally invasive treatment of stroke), based on imaging criteria. Featured Worldwide Stroke Findings: Since new AHA/ASA stroke guidelines and an extended window of potential treatment went into effect in January 2018, the number of suspected stroke patients undergoing RAPID imaging, at centers live in both 2017 and 2019, has increased by more than 100% worldwide (24,644 in 2017 and 51,261 in just the first 9 months of 2019). This suggests stroke centers have substantially increased the number of patients that undergo advanced imaging and can potentially be treated. There was over a 300% increase in suspected stroke patients scanned since 2018 in Primary Stroke Centers (10,080 in 2018 and 35,517 in the first 9 months of 2019). With most scans traditionally taking place in Comprehensive Stroke Centers (CSC), these data show a large percentage increase in scans that occurred in PSCs. This suggests a movement in initial stroke imaging from specialized centers to primary stroke centers and community hospitals, as well as an expansion of stroke care in suburban and rural areas. In the US, the largest number of scans, based on RAPID data, are being done in the “Stroke Belt” region of the southeast, particularly for patients between 65 and 74 years old. Worldwide, women are undergoing advanced imaging for suspected strokes at a slightly, but consistently higher rate than men, based on RAPID data (211,135 women and 201,425 men in 2019). “This World Stroke Day we can really see in the numbers that AI-enhanced medical imaging, along with newer 24-hour stroke treatment guidelines, are making a substantial difference in stroke care around the globe,” said Don Listwin, CEO of iSchemaView. “Whether it’s more imaging at PSCs or more thrombectomies now indicated, it all supports our goal of better outcomes for more people.” The 2018 American Heart Association and American Stroke Association guidelines have significantly altered and expanded the management of acute stroke. Several of the studies that led to these new guidelines were led by Greg Albers, Professor of Neurology at Stanford University, Director of the Stanford Stroke Center and Co-founder of iSchemaView. Please also join Dr. Greg Albers on October 29, 2019, at 3:00pm ET, for a special World Stroke Day Webinar, The Transparent Time Window: A New Perspective on Stroke Treatment.
featured-image

Press Release

Rapid Platform Expands to Address Hemorrhagic Stroke

AI-powered Rapid ICH advanced imaging quickly notifies clinicians of possible intracranial hemorrhage. San Francisco, Calif. – October 21, 2019 – iSchemaView, the worldwide leader in advanced imaging for stroke, today launched the newest addition to the RAPID platform, RAPID ICH1 at the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting. This fully-automated system uses the latest in artificial intelligence to quickly triage non-contrast CT (NCCT) cases and notify clinicians of possible intracranial hemorrhage (ICH). RAPID ICH will enable hospitals and mobile stroke units on the front lines of stroke patient assessment to better streamline treatment decision making. For a demonstration, visit RAPID at CNS Booth #229. RAPID ICH can detect all types of brain hemorrhages with a sensitivity and specificity greater than 90%. This innovative technology was developed and validated using over a thousand CT scans from stroke centers worldwide. This new RAPID module automatically processes images from a scanner and assesses them for hemorrhage. Results are immediately available to doctors via PACS/Workstation, RAPID Mobile app and email. “RAPID ICH is the next step in AI-powered imaging technology,” said Dr. Greg Albers, Professor of Neurology at Stanford University, Director of the Stanford Stroke Center and cofounder of iSchemaView. “By providing radiologists, neurologists and other clinicians this level of detection for all types of hemorrhages in such a small window of time, from minutes compared to the current standard of care of more than an hour, will promote better and faster decision making for improved patient care and outcomes. RAPID ICH will be extremely useful to facilitate triage decisions in both primary stroke centers and mobile stroke units.” Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. It is the only clinically validated imaging solution for stroke diagnostic support worldwide. This proven platform is being used for more than 350,000 scans per year by thousands of healthcare professionals in over 40 countries. The Complete RAPID Platform now includes: RAPID CTP: fully-automated perfusion maps; accurately quantifies reduced cerebral blood flow, cerebral blood volume and transit time RAPID MRI: fully-automated diffusion and perfusion maps that quantify brain areas with low ADC values, as well as delayed contrast arrival RAPID CTA: automatically delivers CT angiography maps and identifies brain regions with reduced blood vessel density in 2D and 3D outputs RAPID ASPECTS: automatically identifies areas of early ischemic change on non-contrast CT scans, which predicts irreversible injury RAPID ICH: automatically triages non-contrast CT scans to quickly identify brain hemorrhages with a sensitivity and specificity >90% RAPID Mobile: securely preview RAPID results from multiple sites with customizable notifications on mobile devices “The innovative technology used in RAPID ICH taps into the latest in artificial intelligence to help clinicians make life saving decisions,” said Don Listwin, CEO of iSchemaView. “RAPID ICH’s highly accurate detection of possible intracranial hemorrhages expands RAPID’s offerings past ischemic events to also include hemorrhagic. In the end, this gives stroke care teams the ability to successfully identify and treat more stroke patients than ever before.”
featured-image

Press Release

Rapid receives registration approval in Japan

Rapid is now available to hospitals across Japan, helping doctors in that country make smart, fast treatment decisions around stroke. Menlo Park, Calif. — July 8, 2019 – iSchemaView, the worldwide leader in advanced imaging for stroke, has received registration approval under the Japanese Pharmaceutical Affairs Law through third-party review by the Japanese Association for the Advancement of Medical Equipment for its RAPID imaging platform. With this news the technology is available to hospitals across Japan, with the support of Micron, the Japanese RAPID distributor. RAPID is designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke. “Stroke remains the fourth most common cause of death in Japan, and as the population ages, stroke is likely to become an increasing health burden on the country,” said Dr. Manabu Inoue from National Cerebral and Cardiovascular Center. “With RAPID’s AI-powered imaging technology we will be able to better address our patients to provide them with the best routes of care, improving their chances of recovery.” Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring). Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, text, the RAPID app or corporate partner workflow systems. The Complete RAPID Platform includes: RAPID CTP: fully-automated perfusion maps; accurately quantifies reduced cerebral blood flow, cerebral blood volume and transit time RAPID MRI: fully-automated diffusion and perfusion maps that quantify brain areas with low ADC values, as well as delayed contrast arrival RAPID CTA: automatically delivers CT angiography maps and identifies brain regions with reduced blood vessel density in 2D and 3D outputs RAPID ASPECTS: automatically identifies areas of early ischemic change on non-contrast CT scans, which predicts irreversible injury RAPID Mobile App : Securely review RAPID results from multiple sites with customizable notifications “With approval for RAPID in Japan, we extend a global footprint that gives more hospitals the tools they need to help stroke patients achieve the best outcomes and quality of life,” said Anil Singhal, MD, SVP, Worldwide Operations at iSchemaView. “Our goal is to help as many stroke patients as possible by delivering the only clinically validated, next-generation imaging technology available.” For more information about working with RAPID in Japan, contact Alex Oh, VP International Sales for APAC at +1 (949) 232-3365 or Oh@RAPID.ai . About Micron Micron is a Japanese leading imaging CRO and provides clinical trial support services with expertise in medical image handling. Micron offers a wide range of services, including imaging protocol standardization, image analysis, site management, and clinical monitoring to enhance the efficiency, reproducibility, and reliability of clinical trials. The company also engages in the development, sales, and marketing of the imaging analysis software which can be utilized in clinical trials for evaluating the efficacy or safety of drugs and in clinical disease progression. RAPID is one of such software, and was approved as a medical device by Pharmaceutical Affairs Law successfully in a short period of time with the great contribution of Micron. For more information, visit www.micron-kobe.com
featured-image

Press Release

International approval update

Menlo Park, Calif. —June 19, 2019 – International Approval Update: iSchemaView has received representative approval of its official manufacturing representatives from the Kingdom of Saudi Arabia’s Ministry of Health (MOH), for the RAPID imaging platform. RAPID product approval is pending in the Kingdom of Saudi Arabia.
featured-image

Press Release

Rapid now available for use in Mexico

Rapid grows international footprint and brings Mexico the only clinically validated, next-generation imaging platform for assessing ischemic stroke Menlo Park, Calif. —June 18, 2019 – iSchemaView, the worldwide leader in advanced imaging for stroke, has expanded its reach across North and Latin America, as the RAPID imaging platform is now available for use in Mexico. RAPID is designed to provide physicians with fully automated and easy-to-interpret imaging that facilitates timely clinical decision-making around stroke. "Strokes are a medical emergency, and urgent treatment is essential. The sooner a person receives treatment for a stroke, the less damage is likely to happen. That's why Punta Mita Hospital has acquired the most advanced cerebrovascular imaging platform available, RAPID,” offered Dr. Luis Alberto López Avelar, Medical Director Punta Mita Hospital. “We are committed to offering the best quality in medical care, which is why now with RAPID Punta Mita Hospital provides state-of-the-art technology for the timely and accurate diagnosis of a cerebrovascular event." Developed by leading stroke experts, RAPID technology has been selected for use in several ground-breaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring). Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, text, the RAPID app or corporate partner workflow systems. The Complete RAPID Platform includes: RAPID CTP: fully-automated perfusion maps; accurately quantifies reduced cerebral blood flow, cerebral blood volume and transit time RAPID MRI: fully-automated diffusion and perfusion maps that quantify brain areas with low ADC values, as well as delayed contrast arrival RAPID CTA: automatically delivers CT angiography maps and identifies brain regions with reduced blood vessel density in 2D and 3D outputs RAPID ASPECTS: automatically identifies areas of early ischemic change on non-contrast CT scans, which predicts irreversible injury “Each day we work to transform stroke care, furthering our mission to provide healthcare professionals around the globe with the most comprehensive and intuitive suite of brain imaging solutions possible.” said Anil Singhal, MD, SVP, Worldwide Operations at iSchemaView. “Based on just the first quarter of this year, RAPID is already on pace to image over 132,500 patients in 2019, process over 250,000 scans and identify over 40,000 potential patients for thrombectomies. We will continue to expand, across Mexico and the globe, to provide as many hospitals as possible the tools they need to best help their patients and improve outcomes.” For more information about working with RAPID in Mexico, contact renatocunha@rapid.ai .
featured-image

Press Release

iSchemaView Launches Rapid U

New learning system and certification program sets international standard for professional status as a RAPID imaging practitioner. Empowers multiple members of stroke care teams to quickly become proficient. Menlo Park, Calif. —May 20, 2019 – iSchemaView, the worldwide leader in advanced imaging for stroke, has launched RAPID U, a training certification program for iSchemaView’s RAPID technology. An imaging standard around the world, RAPID is the platform designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke. Powered by a mobile-first learning management system, RAPID U provides role-based learning paths for various members of stroke care teams, including imaging technologists, stroke coordinators, neuroradiologists, neurologists and neurointerventionalists. The program is resource-rich for a robust education. It is enhanced with videos, case studies, publications, and clinical trials information across 15 courses, which cover all aspects of RAPID modules and products, and is supplemented with live sessions. "All aspects of the RAPID U certification program were developed by RAPID clinical and technology experts. It is unique, in that stroke care teams will be able to learn advanced imaging from the experts,” said Dr. Greg Albers, professor of Neurology at Stanford University, director of the Stanford Stroke Center and cofounder of iSchemaView. “iSchemaView is very excited to offer free RAPID certification to all customers via this new learning platform. As the availability of advanced stroke imaging continues to expand, it is vital for hospitals to have skilled individuals on their stroke care teams. RAPID U will help ensure that stroke care team members are fully trained on how to use RAPID effectively, and have a positive impact on patient outcomes.” RAPID U is accessible from the desktop and mobile apps. This allows the stroke team to take courses and obtain certificates at their own pace, when and where they choose. Clinicians can become RAPID certified following the successful completion of each course, and can have the option to continue on to more advanced courses. "Moving forward, RAPID U will provide increased visibility into clinical team readiness,” said Anil Singhal, MD, SVP, Worldwide Operations at iSchemaView. “This will allow an understanding of which modules are of particular interest, and move on to more advanced training as needed. Most importantly, this educational program will enable more members of the stroke care team to optimize RAPID in reducing the debilitating impacts of stroke.” Developed by leading stroke experts, RAPID technology has been selected for use in several groundbreaking trials that have changed treatment guidelines issued by both the American Heart Association and American Stroke Association. The RAPID Artificial Intelligence framework combines deep learning, machine learning and expert feature extraction. Together these provide unparalleled sensitivity and specificity across stroke modules (CT perfusion, MR diffusion and perfusion, CTA and CT ASPECT scoring). Results are then delivered by the RAPID Intelligence Services Platform via PACS, email, text, the RAPID app or corporate partner workflow systems. For more information about RAPID U, contact training@rapid.ai.
featured-image

Press Release

Data Suggests New Guidelines in Stroke Care Have Led to Record Numbers of Patients Treated

Over 100% more mechanical thrombectomies indicated from 2017 to 2018, according to data from Rapid market intelligence Menlo Park, Calif. —May 15, 2019 – May is Stroke Awareness Month and in commemoration, iSchemaView, the worldwide leader in advanced imaging for stroke, is releasing its first market intelligence data from RAPID. The RAPID platform is designed to provide physicians with fast, fully automated, and easy-to-interpret imaging that facilitates clinical decision-making around stroke. Stroke afflicts around 800,000 Americans each year and ranks as the number five cause of death and the number one cause of disability in the United States. New RAPID data reveals that over 40,000 more patients’ lives were impacted in 2018 over 2017 via this advanced technology, more than doubling the number of patients scanned and thrombectomies indicated by imaging. iSchemaView’s RAPID has changed how physicians approach stroke care. From 2017 to 2018 there was over a 100% increase in patients imaged with RAPID worldwide (41,125 in 2017 and 82,365 in 2018). Perfusion imaging criteria was met for thrombectomy in 12,285 patients in 2017 and 25,269 in 2018. Based on the first quarter of 2019, RAPID is on pace to image over 132,500 patients in 2019 and identify over 40,000 potential patients for thrombectomies. The platform is also estimated to process over 250,000 total scans this year. While the above represents dramatic overall growth in patients addressed and thrombectomies indicated around the world, there was also significant same-site growth. Looking only at care sites active with the RAPID platform in 2017 as compared to the same sites in 2018, there was over a 50% growth in patients addressed (39,955 in 2017 and 60,821 in 2018), and potential thrombectomies indicated (11,811 in 2017 and 17,742 in 2018). This dramatic expansion in patients scanned tracks with new 2018 American Heart Association and American Stroke Association guidelines that have dramatically altered the management of acute stroke. These new guidelines were established after a series of studies were conducted and published by iSchemaView co-founder, Dr. Greg Albers and others. “RAPID has greatly impacted our ability to offer life- and disability-saving care to our patients,” said Cherylee Chang, M.D., medical director, Neuroscience Institute/Neurocritical Care at The Queen's Medical Center. “In 2017 we performed 37 thrombectomies; this increased to 93 in 2018 and we have already exceeded 30 cases in the first 3 months of 2019. Due to the ability of our stroke team, which includes our neurointerventionalists, to receive immediate results of RAPID’s perfusion imaging, our median door-to-puncture time is 46 minutes. RAPID has revolutionized stroke care.” “It is now just over a year since the simultaneous publication of DEFUSE 3 and the new 24-hour stroke treatment guidelines. Taking a look at the latest treatment numbers, it seems clear that the imaging-based studies have already made a huge impact on stroke care worldwide,” said Dr. Greg Albers, professor of neurology at Stanford University, director of the Stanford Stroke Center and co-founder of iSchemaView. “By building on the artificial intelligence and advanced imaging technology in RAPID, we will continue to contribute to increased treatment rates which will lead to a major reduction in stroke disability and mortality.”
5 6 7 8 9